Why the study?
Does streptokinase treatment reduce mortality in patients with acute myocardial infarction?
Population
426 patients admitted with symptoms of acute myocardial infarction across four hospitals
Comparison
Streptokinase (SK), 600,000 IU or more vs Control group receiving standard care without…
Design
Cohort
Follow-up
six weeks
Authors
Loading...
No mortality benefit observed with streptokinase; leaves open efficacy in acute MI pending randomized trials.
Does streptokinase treatment reduce mortality in patients with acute myocardial infarction?
In this early study, streptokinase treatment did not demonstrate a mortality benefit at six weeks in patients with acute myocardial infarction.
Heikinheimo et al. (1971) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: